Med-Chemist : "Quintessential Medicinal Chemistry"
Friday, September 6, 2013
AstraZeneca and Bristol-Myers Squibb resubmit Dapagliflozin New Drug Application for the treatment of type 2 diabetes in the U.S
In continuation of my update on
Dapagliflozin
AstraZeneca and Bristol-Myers Squibb resubmit Dapagliflozin New Drug Application for the treatment of type 2 diabetes in the U.S
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment